Payal Ganguly is a Project Manager (research associate) in the Leeds Institute of Rheumatic and Musculoskeletal Medicine (LIRMM) at the University of Leeds, UK. Her current role focuses on age-related musculoskeletal diseases and their clinical investigations. Prior to this, her research focused on the effect of pharmaceutical agents on patient derived 3D-tissue explants for rheumatoid arthritis. She has also worked on investigating bone marrow mesenchymal stromal/stem cells (MSCs) in ageing, and their potential in tissue engineering and regenerative medicine. She graduated with a Bachelor of Pharmacy from NMIMS University, Mumbai, India, and also holds a Master’s degree in Nanomedicine from Newcastle University, UK. She holds a PhD in Medicine and prior to that, she worked as a project assistant in a nanomedicine research group at the Institute of Chemical Technology, Mumbai. She then worked as a research engineer under a Bill and Melinda Gates-funded project for novel transdermal drug delivery systems in the nanomedicine laboratory at the Indian Institute of Technology (IIT), Mumbai. Her research interests include anti-ageing strategies using biomaterials, biologics and pharmacological interventions. Since her PhD, she has gained a broad range of expertise including arthritis, stem cells, aging, in vitro modelling, tissue engineering and nanomedicines.